• SENSEX
    NIFTY 50
Market

This pharma stock rose over 40% amid pandemic, ICICI Direct sees more upside still

Updated : July 20, 2020 05:57 PM IST

Pharma company Cipla has outperformed benchmarks and pharma index in the year 2020 on a year-to-date basis
In a recent report, ICICI Direct suggested another 15 percent upside for the stock.
It is also one of the 6 stocks that have received earnings upgrade from brokerage CLSA for FY22.
This pharma stock rose over 40% amid pandemic, ICICI Direct sees more upside still

You May Also Like

Live TV
Advertisement